Baseline clinical characteristics predict overall survival in patients undergoing radioligand therapy with [<sup>177</sup>Lu]Lu-PSMA I&T during long-term follow-up.

Eur J Nucl Med Mol Imaging · 2022 · PMC9525362 · PMID 35650263

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

failed to reach significanceno p-value reported

Moreover, 12/92 patients received reduced activity in at least one cycle, but failed to reach significance in a univariate analysis (Table 2 ).

also in 4,113 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.